This article is more than 5 years old. Information may no longer be current.

PTA dilatation catheter launched in US, Europe and Japan

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Cordis Corporation has announced the clearance and launch of its Saber PTA dilatation catheter in the United States, Europe and Japan for the treatment of patients with peripheral arterial disease.

The new catheter features a durable dual-layer hydrophilic coating with a low-profile body and new molded tip for enhanced crossability. It is designed for the 0.018-inch over-the-wire platform and is available in several sizes, including balloon diameters of 2 mm to 10 mm and lengths of 20 mm to 300 mm.

According to a press release, the device was developed to complement the Cordis PTA portfolio and is used to dilate stenoses in iliac, femoral, iliofemoral, popliteal, infrapopliteal and renal arteries, as well as to treat obstructive lesions of native or synthetic arteriovenous dialysis fistulae. The catheter also can be used for post-dilatation of balloon-expandable and self-expanding stents in the peripheral anatomy.